Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

NCT07214324 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT07214324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07214324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Observational
Overall status
Recruiting
Start date
March 17, 2025
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

monoclonal gammopathy of undetermined significance (mgus), multiple myeloma (mm), smoldering multiple myeloma (smm)